1266 related articles for article (PubMed ID: 16354625)
1. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
[TBL] [Abstract][Full Text] [Related]
2. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Marangon FB; Miller D; Giaconi JA; Alfonso EC
Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China.
Xie L; Zhai H; Zhao J; Sun S; Shi W; Dong X
Am J Ophthalmol; 2008 Aug; 146(2):260-265. PubMed ID: 18547535
[TBL] [Abstract][Full Text] [Related]
4. Ocular fungal isolates and antifungal susceptibility in northern China.
Xuguang S; Zhixin W; Zhiqun W; Shiyun L; Ran L
Am J Ophthalmol; 2007 Jan; 143(1):131-133. PubMed ID: 17188047
[TBL] [Abstract][Full Text] [Related]
5. Exogenous fungal endophthalmitis: microbiology and clinical outcomes.
Wykoff CC; Flynn HW; Miller D; Scott IU; Alfonso EC
Ophthalmology; 2008 Sep; 115(9):1501-7, 1507.e1-2. PubMed ID: 18486220
[TBL] [Abstract][Full Text] [Related]
6. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
[TBL] [Abstract][Full Text] [Related]
8. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
[TBL] [Abstract][Full Text] [Related]
9. Fungal keratitis in London: microbiological and clinical evaluation.
Galarreta DJ; Tuft SJ; Ramsay A; Dart JK
Cornea; 2007 Oct; 26(9):1082-6. PubMed ID: 17893539
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
Pearce JW; Giuliano EA; Moore CP
Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006).
Ledbetter EC; Patten VH; Scarlett JM; Vermeylen FM
J Am Vet Med Assoc; 2007 Oct; 231(7):1086-91. PubMed ID: 17916036
[TBL] [Abstract][Full Text] [Related]
12. [The clinical and pathogenic characteristics of keratitis caused by Alternaria alternata].
Sun ST; Wang LY; Xu J; Wei QC; Li JX
Zhonghua Yan Ke Za Zhi; 2007 Jan; 43(1):32-5. PubMed ID: 17442160
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
Shobana CS; Mythili A; Homa M; Galgóczy L; Priya R; Babu Singh YR; Panneerselvam K; Vágvölgyi C; Kredics L; Narendran V; Manikandan P
J Mycol Med; 2015 Mar; 25(1):44-9. PubMed ID: 25541256
[TBL] [Abstract][Full Text] [Related]
14. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
Buchta V; Vejsova M; Vale-Silva LA
Folia Microbiol (Praha); 2008; 53(2):153-60. PubMed ID: 18837162
[TBL] [Abstract][Full Text] [Related]
15. [Multicenter Prospective Observational Study of Fungal Keratitis--Identification and Susceptibility Test of Fungi].
Sunada A; Asari S; Inoue Y; Ohashi Y; Suzuki T; Shimomura Y; Fukuda M; Sotozono C; Hatano H; Eguchi H; Araki-Sasaki K; Hoshi S; Yaguchi T; Makimura K; Yokokura S; Mochizuki K; Monden Y; Nejima R;
Nippon Ganka Gakkai Zasshi; 2016 Jan; 120(1):17-27. PubMed ID: 26950965
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
17. In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis.
Weinstein WL; Moore PA; Sanchez S; Dietrich UM; Wooley RE; Ritchie BW
Am J Vet Res; 2006 Apr; 67(4):562-8. PubMed ID: 16579746
[TBL] [Abstract][Full Text] [Related]
18. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
Iqbal NJ; Boey A; Park BJ; Brandt ME
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals.
Arredondo-García JL; Amábile-Cuevas CF;
J Infect Dev Ctries; 2009 Jun; 3(5):398-401. PubMed ID: 19759511
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study.
Agarwal PK; Roy P; Das A; Banerjee A; Maity PK; Banerjee AR
Indian J Ophthalmol; 2001 Sep; 49(3):173-6. PubMed ID: 15887725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
